Cargando…

Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease

AIMS: Mitochondrial disorders are among the most frequently inherited cause of neurological disease and arise due to mutations in mitochondrial or nuclear DNA. Currently, we do not understand the specific involvement of certain brain regions or selective neuronal vulnerability in mitochondrial disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Lax, Nichola Z., Grady, John, Laude, Alex, Chan, Felix, Hepplewhite, Philippa D., Gorman, Grainne, Whittaker, Roger G., Ng, Yi, Cunningham, Mark O., Turnbull, Doug M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772453/
https://www.ncbi.nlm.nih.gov/pubmed/25786813
http://dx.doi.org/10.1111/nan.12238
_version_ 1782418571144462336
author Lax, Nichola Z.
Grady, John
Laude, Alex
Chan, Felix
Hepplewhite, Philippa D.
Gorman, Grainne
Whittaker, Roger G.
Ng, Yi
Cunningham, Mark O.
Turnbull, Doug M.
author_facet Lax, Nichola Z.
Grady, John
Laude, Alex
Chan, Felix
Hepplewhite, Philippa D.
Gorman, Grainne
Whittaker, Roger G.
Ng, Yi
Cunningham, Mark O.
Turnbull, Doug M.
author_sort Lax, Nichola Z.
collection PubMed
description AIMS: Mitochondrial disorders are among the most frequently inherited cause of neurological disease and arise due to mutations in mitochondrial or nuclear DNA. Currently, we do not understand the specific involvement of certain brain regions or selective neuronal vulnerability in mitochondrial disease. Recent studies suggest γ‐aminobutyric acid (GABA)‐ergic interneurones are particularly susceptible to respiratory chain dysfunction. In this neuropathological study, we assess the impact of mitochondrial DNA defects on inhibitory interneurones in patients with mitochondrial disease. METHODS: Histochemical, immunohistochemical and immunofluorescent assays were performed on post‐mortem brain tissue from 10 patients and 10 age‐matched control individuals. We applied a quantitative immunofluorescent method to interrogate complex I and IV protein expression in mitochondria within GABAergic interneurone populations in the frontal, temporal and occipital cortices. We also evaluated the density of inhibitory interneurones in serial sections to determine if cell loss was occurring. RESULTS: We observed significant, global reductions in complex I expression within GABAergic interneurones in frontal, temporal and occipital cortices in the majority of patients. While complex IV expression is more variable, there is reduced expression in patients harbouring m.8344A>G point mutations and POLG mutations. In addition to the severe respiratory chain deficiencies observed in remaining interneurones, quantification of GABAergic cell density showed a dramatic reduction in cell density suggesting interneurone loss. CONCLUSIONS: We propose that the combined loss of interneurones and severe respiratory deficiency in remaining interneurones contributes to impaired neuronal network oscillations and could underlie development of neurological deficits, such as cognitive impairment and epilepsy, in mitochondrial disease.
format Online
Article
Text
id pubmed-4772453
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-47724532016-04-20 Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease Lax, Nichola Z. Grady, John Laude, Alex Chan, Felix Hepplewhite, Philippa D. Gorman, Grainne Whittaker, Roger G. Ng, Yi Cunningham, Mark O. Turnbull, Doug M. Neuropathol Appl Neurobiol Original Articles AIMS: Mitochondrial disorders are among the most frequently inherited cause of neurological disease and arise due to mutations in mitochondrial or nuclear DNA. Currently, we do not understand the specific involvement of certain brain regions or selective neuronal vulnerability in mitochondrial disease. Recent studies suggest γ‐aminobutyric acid (GABA)‐ergic interneurones are particularly susceptible to respiratory chain dysfunction. In this neuropathological study, we assess the impact of mitochondrial DNA defects on inhibitory interneurones in patients with mitochondrial disease. METHODS: Histochemical, immunohistochemical and immunofluorescent assays were performed on post‐mortem brain tissue from 10 patients and 10 age‐matched control individuals. We applied a quantitative immunofluorescent method to interrogate complex I and IV protein expression in mitochondria within GABAergic interneurone populations in the frontal, temporal and occipital cortices. We also evaluated the density of inhibitory interneurones in serial sections to determine if cell loss was occurring. RESULTS: We observed significant, global reductions in complex I expression within GABAergic interneurones in frontal, temporal and occipital cortices in the majority of patients. While complex IV expression is more variable, there is reduced expression in patients harbouring m.8344A>G point mutations and POLG mutations. In addition to the severe respiratory chain deficiencies observed in remaining interneurones, quantification of GABAergic cell density showed a dramatic reduction in cell density suggesting interneurone loss. CONCLUSIONS: We propose that the combined loss of interneurones and severe respiratory deficiency in remaining interneurones contributes to impaired neuronal network oscillations and could underlie development of neurological deficits, such as cognitive impairment and epilepsy, in mitochondrial disease. John Wiley and Sons Inc. 2015-05-30 2016-02 /pmc/articles/PMC4772453/ /pubmed/25786813 http://dx.doi.org/10.1111/nan.12238 Text en © 2015 The Authors. Neuropathology and Applied Neurobiology published by John Wiley & Sons Ltd on behalf of British Neuropathological Society. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Lax, Nichola Z.
Grady, John
Laude, Alex
Chan, Felix
Hepplewhite, Philippa D.
Gorman, Grainne
Whittaker, Roger G.
Ng, Yi
Cunningham, Mark O.
Turnbull, Doug M.
Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease
title Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease
title_full Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease
title_fullStr Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease
title_full_unstemmed Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease
title_short Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease
title_sort extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772453/
https://www.ncbi.nlm.nih.gov/pubmed/25786813
http://dx.doi.org/10.1111/nan.12238
work_keys_str_mv AT laxnicholaz extensiverespiratorychaindefectsininhibitoryinterneuronesinpatientswithmitochondrialdisease
AT gradyjohn extensiverespiratorychaindefectsininhibitoryinterneuronesinpatientswithmitochondrialdisease
AT laudealex extensiverespiratorychaindefectsininhibitoryinterneuronesinpatientswithmitochondrialdisease
AT chanfelix extensiverespiratorychaindefectsininhibitoryinterneuronesinpatientswithmitochondrialdisease
AT hepplewhitephilippad extensiverespiratorychaindefectsininhibitoryinterneuronesinpatientswithmitochondrialdisease
AT gormangrainne extensiverespiratorychaindefectsininhibitoryinterneuronesinpatientswithmitochondrialdisease
AT whittakerrogerg extensiverespiratorychaindefectsininhibitoryinterneuronesinpatientswithmitochondrialdisease
AT ngyi extensiverespiratorychaindefectsininhibitoryinterneuronesinpatientswithmitochondrialdisease
AT cunninghammarko extensiverespiratorychaindefectsininhibitoryinterneuronesinpatientswithmitochondrialdisease
AT turnbulldougm extensiverespiratorychaindefectsininhibitoryinterneuronesinpatientswithmitochondrialdisease